Determining safe alternatives for multidrug hypersensitive patients with the alternative triple antibiotic-analgesic test.
Allergol Immunopathol (Madr) 2012 May 3;
abstract
_______________________________________________________________
5
Study of wheezing and its risk factors in the first year of life in the Province of Salamanca, Spain. The EISL Study.
Allergol Immunopathol (Madr) 2012 May;40(3):164-171
abstract
_______________________________________________________________
6
Microarray based IgE detection in poly-sensitized allergic patients with suspected food allergy - an approach in four clinical cases.
Allergol Immunopathol (Madr) 2012 May;40(3):172-180
abstract
_______________________________________________________________
7
Aspirin-Intolerant Asthma (AIA) Assessment Using the Urinary Biomarkers, Leukotriene E(4)(LTE(4)) and Prostaglandin D(2)(PGD(2)) Metabolites.
Allergol Int 2012 May 25;0(0):
abstract
_______________________________________________________________
8
Inhibition of Common Cold-Induced Aggravation of Childhood Asthma by Leukotriene Receptor Antagonists.
Allergol Int 2012 May 25;0(0):
abstract
_______________________________________________________________
9
Superiority of nebulized corticosteroids over dry powder inhalers in certain patients with cough variant asthma or cough-predominant asthma.
Allergol Int 2012 May 25;0(0):
abstract
_______________________________________________________________
10
Prevention and control of childhood asthma and allergy in the EU from the public health point of view: Polish Presidency of the European Union.
Allergy 2012 Apr 28;
abstract
_______________________________________________________________
11
Bronchoalveolar lavage fluid exosomes contribute to cytokine and leukotriene production in allergic asthma.
Allergy 2012 May 23;
abstract
_______________________________________________________________
12
Topical application of PPARalpha (but not beta/delta or gamma) suppresses atopic dermatitis in NC/Nga mice.
Allergy 2012 May 15;
abstract
_______________________________________________________________
13
Efficacy and safety of the interleukin-1 antagonist rilonacept in Schnitzler syndrome: an open-label study.
Allergy 2012 May 15;
abstract
_______________________________________________________________
14
Increased expression of IL-19 in the epithelium of patients with chronic rhinosinusitis and nasal polyps.
Allergy 2012 May 14;
abstract
_______________________________________________________________
15
Prenatal exposure to allergen, DNA methylation, and allergy in grandoffspring mice.
Allergy 2012 May 14;
abstract
_______________________________________________________________
16
Diagnostic evaluation of patients with nonimmediate cutaneous hypersensitivity reactions to iodinated contrast media.
Allergy 2012 May 15;
abstract
_______________________________________________________________
17
Outcome of oral food challenges in children in relation to symptom-eliciting allergen dose and allergen-specific IgE.
Allergy 2012 May 14;
abstract
_______________________________________________________________
18
Expression profiles of regulatory and helper T-cell-associated genes in nasal polyposis.
Allergy 2012 Mar 30;
abstract
_______________________________________________________________
19
Increased serum baseline tryptase levels and extensive skin involvement are predictors for the severity of mast cell activation episodes in children with mastocytosis.
Allergy 2012 Mar 28;
abstract
_______________________________________________________________
20
Sustained effects of grass pollen AIT.
Allergy 2011 Jul;66 Suppl 9550-52
abstract
_______________________________________________________________
21
Untangling asthma phenotypes and endotypes.
Allergy 2012 May 17;
abstract
_______________________________________________________________
22
Corticosteroid treatment selectively decreases mast cells in the smooth muscle and epithelium of asthmatic bronchi.
Allergy 2012 May 14;
abstract
_______________________________________________________________
23
NI-1: a novel canine mastocytoma model for studying drug resistance and IgER-dependent mast cell activation.
Allergy 2012 May 15;
abstract
_______________________________________________________________
24
Ragweed pollen collected along high-traffic roads shows a higher allergenicity than pollen sampled in vegetated areas.
Allergy 2012 May 14;
abstract
_______________________________________________________________
25
DNA methylation levels within the CD14 promoter region are lower in placentas of mothers living on a farm.
Allergy 2012 May 7;
abstract
_______________________________________________________________
26
Recombinant IGFBP-3 inhibits allergic lung inflammation, VEGF production, and vascular leak in a mouse model of asthma.
Allergy 2012 May 7;
abstract
_______________________________________________________________
27
Surveillance of contact allergies: methods and results of the Information Network of Departments of Dermatology (IVDK).
Allergy 2012 May 7;
abstract
_______________________________________________________________
28
Anaphylaxis to pork kidney is related to IgE antibodies specific for galactose-alpha-1,3-galactose.
Allergy 2012 May;67(5):699-704
abstract
_______________________________________________________________
29
Basophils and antigen presentation: of mice and not men?
Allergy 2012 May;67(5):579-580
abstract
_______________________________________________________________
30
Role of specific IgE and skin-prick testing in predicting food challenge results to baked egg.
Allergy Asthma Proc 2012 May;33(3):275-281
abstract
_______________________________________________________________
31
Discrepancies between guidelines and international practice in treatment of hereditary angioedema.
Allergy Asthma Proc 2012 May;33(3):241-248
abstract
_______________________________________________________________
32
Current options for prophylactic treatment of hereditary angioedema in the United States: patient-based considerations.
Allergy Asthma Proc 2012 May;33(3):235-240
abstract
_______________________________________________________________
33
Epidemiology of atopic dermatitis: a review.
Allergy Asthma Proc 2012 May;33(3):227-234
abstract
_______________________________________________________________
34
Rapid diagnosis of Mycobacterium tuberculosis infection in children using interferon-gamma release assays (IGRAs).
Allergy Asthma Proc 2012 May;33(3):217-226
abstract
_______________________________________________________________
35
What every physician should know about rapid diagnosis of Mycobacterium tuberculosis infection in children using interferon-gamma release assays.
Allergy Asthma Proc 2012 May;33(3):215-216
abstract
_______________________________________________________________
36
Prolonged urticaria and fever in a toddler.
Allergy Asthma Proc 2012 May;33(3):297-301
abstract
_______________________________________________________________
37
Assessment of the association between atopic conditions and tympanostomy tube placement in children.
Allergy Asthma Proc 2012 May;33(3):289-296
abstract
_______________________________________________________________
38
Effect of cat and daycare exposures on the risk of asthma in children with atopic dermatitis.
Allergy Asthma Proc 2012 May;33(3):282-288
abstract
_______________________________________________________________
39
The first probable case of hereditary angioedema in Vietnam.
Allergy Asthma Immunol Res 2012 May;4(3):165-167
abstract
_______________________________________________________________
40
A case of hypereosinophilic syndrome presenting with multiorgan infarctions associated with disseminated intravascular coagulation.
Allergy Asthma Immunol Res 2012 May;4(3):161-164
abstract
_______________________________________________________________
41
Changes in major peanut allergens under different pH conditions.
Allergy Asthma Immunol Res 2012 May;4(3):157-160
abstract
_______________________________________________________________
42
Asthma Prevention by Lactobacillus Rhamnosus in a Mouse Model is Associated With CD4(+)CD25(+)Foxp3(+) T Cells.
Allergy Asthma Immunol Res 2012 May;4(3):150-156
abstract
_______________________________________________________________
43
The HLA-DRB1 Polymorphism is Associated With Atopic Dermatitis, but not Egg Allergy in Korean Children.
Allergy Asthma Immunol Res 2012 May;4(3):143-149
abstract
_______________________________________________________________
44
Flow Cytometry-Assisted Basophil Activation Test as a Safe Diagnostic Tool for Aspirin/NSAID Hypersenstivity.
Allergy Asthma Immunol Res 2012 May;4(3):137-142
abstract
_______________________________________________________________
45
Genetic Variations in TXNRD1 as Potential Predictors of Drug-Induced Liver Injury.
Allergy Asthma Immunol Res 2012 May;4(3):132-136
abstract
_______________________________________________________________
46
Influence of asthma epidemiology on the risk for other diseases.
Allergy Asthma Immunol Res 2012 May;4(3):122-131
abstract
_______________________________________________________________
47
Updates in the relationship between human rhinovirus and asthma.
Allergy Asthma Immunol Res 2012 May;4(3):116-121
abstract
_______________________________________________________________
48
Immune tolerance by induced regulatory T cells in asthma.
Allergy Asthma Immunol Res 2012 May;4(3):113-115
abstract
_______________________________________________________________
49
A case of Korean ginseng-induced anaphylaxis confirmed by open oral challenge and basophil activation test.
Allergy Asthma Immunol Res 2012 Mar;4(2):110-111
abstract
_______________________________________________________________
50
Macrophage activation syndrome in a patient with pulmonary inflammatory myofibroblastic tumour.
Allergy Asthma Clin Immunol 2012 May 20;8(1):6
abstract
_______________________________________________________________
51
Skin prick testing with extensively heated milk or egg products helps predict the outcome of an oral food challenge: a retrospective analysis.
Allergy Asthma Clin Immunol 2012 May 16;8(1):5
abstract
_______________________________________________________________
52
Pseudomeningoceles of the sphenoid sinus masquerading as sinus pathology.
Am J Rhinol Allergy 2012 May;26(3):251
abstract
_______________________________________________________________
53
Inferior turbinate composite graft for repair of nasal septal perforation.
Am J Rhinol Allergy 2012 May;26(3):237-242
abstract
_______________________________________________________________
54
Retrieval of projectile foreign bodies from the paranasal sinuses and skull base.
Am J Rhinol Allergy 2012 May;26(3):233-236
abstract
_______________________________________________________________
55
Olfaction in athletes with concussion.
Am J Rhinol Allergy 2012 May;26(3):222-226
abstract
_______________________________________________________________
56
A multiallergen and miniscreen can change primary care provider diagnosis and treatment of rhinitis.
Am J Rhinol Allergy 2012 May;26(3):218-221
abstract
_______________________________________________________________
57
Sinonasal perivascular epithelioid cell tumor: Benign or malignant neoplasm?
Am J Rhinol Allergy 2012 May;26(3):213-217
abstract
_______________________________________________________________
58
The effect of anatomically directed topical steroid drops on frontal recess patency after endoscopic sinus surgery: A prospective randomized single blind study.
Am J Rhinol Allergy 2012 May;26(3):209-212
abstract
_______________________________________________________________
59
Central presentation of postviral olfactory loss evaluated by positron emission tomography scan: A pilot study.
Am J Rhinol Allergy 2012 May;26(3):204-208
abstract
_______________________________________________________________
60
Contamination of sinus irrigation devices: A review of the evidence and clinical relevance.
Am J Rhinol Allergy 2012 May;26(3):201-203
abstract
_______________________________________________________________
61
Surfactant improves irrigant penetration into unoperated sinuses.
Am J Rhinol Allergy 2012 May;26(3):197-200
abstract
_______________________________________________________________
62
Antibiotics in septoplasty: Evidence or habit?
Am J Rhinol Allergy 2012 May;26(3):194-196
abstract
_______________________________________________________________
63
Reduced olfactory bulb volume and diminished olfactory function in total laryngectomy patients: A prospective longitudinal study.
Am J Rhinol Allergy 2012 May;26(3):191-193
abstract
_______________________________________________________________
64
The united allergic airway: Connections between allergic rhinitis, asthma, and chronic sinusitis.
Am J Rhinol Allergy 2012 May;26(3):187-190
abstract
_______________________________________________________________
65
Effects of dexamethasone or methotrexate on chitinolytic activity in nasal polyps.
Am J Rhinol Allergy 2012 May;26(3):183-186
abstract
_______________________________________________________________
66
Down-regulation of gelsolin may play a role in the progression of inverted papilloma through an antiapoptotic mechanism.
Am J Rhinol Allergy 2012 May;26(3):177-182
abstract
_______________________________________________________________
67
Expression and localization of aquaporin 1, 2, 3, 4, and 5 in human nasal mucosa.
Am J Rhinol Allergy 2012 May;26(3):167-171
abstract
_______________________________________________________________
68
Frontal sinus cells: Identification, prevalence, and association with frontal sinus mucosal thickening.
Am J Rhinol Allergy 2012 May;26(3):107-110
abstract
_______________________________________________________________
69
Comparison of lidocaine and levobupivacaine in transnasal fiberoptic laryngoscopy.
Am J Rhinol Allergy 2012 May;26(3):104-106
abstract
_______________________________________________________________
70
Nasal nitric oxide in a random sample of adults and its relationship to sensitization, cat allergen, rhinitis, and ambient nitric oxide.
Am J Rhinol Allergy 2012 May;26(3):99-103
abstract
_______________________________________________________________
71
Computed nasal resistance compared with patient-reported symptoms in surgically treated nasal airway passages: A preliminary report.
Am J Rhinol Allergy 2012 May;26(3):94-98
abstract
_______________________________________________________________
72
Is a positive nasal lysine-aspirin challenge test associated with a more severe phenotype of chronic rhinosinusitis and asthma?
Am J Rhinol Allergy 2012 May;26(3):89-93
abstract
_______________________________________________________________
73
Poor asthma control and exposure to traffic pollutants and obesity in older adults.
Ann Allergy Asthma Immunol 2012 Jun;108(6):423-428
abstract
_______________________________________________________________
74
Acute coronary thrombosis after anaphylactic shock treatment.
Ann Allergy Asthma Immunol 2012 May;108(5):380-381
abstract
_______________________________________________________________
75
Impaired cough-related quality of life in patients with controlled asthma with gastroesophageal reflux disease.
Ann Allergy Asthma Immunol 2012 May;108(5):379-380
abstract
_______________________________________________________________
76
Survey on immunotherapy practice patterns: dose, dose adjustments, and duration.
Ann Allergy Asthma Immunol 2012 May;108(5):373-378
abstract
_______________________________________________________________
77
Component-resolved immunologic modifications, efficacy, and tolerance of latex sublingual immunotherapy in children.
Ann Allergy Asthma Immunol 2012 May;108(5):367-372
abstract
_______________________________________________________________
78
Conservative long-term treatment of children with eosinophilic esophagitis.
Ann Allergy Asthma Immunol 2012 May;108(5):363-366
abstract
_______________________________________________________________
79
Effects of intranasal mometasone furoate on itchy ear and palate in patients with seasonal allergic rhinitis.
Ann Allergy Asthma Immunol 2012 May;108(5):359-362
abstract
_______________________________________________________________
80
Efficacy and immunological actions of FAHF-2 in a murine model of multiple food allergies.
Ann Allergy Asthma Immunol 2012 May;108(5):351-358
abstract
_______________________________________________________________
81
Contribution of interleukin 17A to the development and regulation of allergic inflammation in a murine allergic rhinitis model.
Ann Allergy Asthma Immunol 2012 May;108(5):342-350
abstract
_______________________________________________________________
82
The role of autoimmune testing in chronic idiopathic urticaria.
Ann Allergy Asthma Immunol 2012 May;108(5):337-341
abstract
_______________________________________________________________
83
Clinical thresholds to egg, hazelnut, milk and peanut: results from a single-center study using standardized challenges.
Ann Allergy Asthma Immunol 2012 May;108(5):332-336
abstract
_______________________________________________________________
84
The natural history of persistent peanut allergy.
Ann Allergy Asthma Immunol 2012 May;108(5):326-331
abstract
_______________________________________________________________
85
Timing the transfer of responsibilities for anaphylaxis recognition and use of an epinephrine auto-injector from adults to children and teenagers: pediatric allergists' perspective.
Ann Allergy Asthma Immunol 2012 May;108(5):321-325
abstract
_______________________________________________________________
86
Allergen of the month-ginkgo.
Ann Allergy Asthma Immunol 2012 May;108(5):A12
abstract
_______________________________________________________________
87
Prevention of anaphylaxis related to mast cell activation syndrome with omalizumab.
Ann Allergy Asthma Immunol 2012 May;108(5):383-384
abstract
_______________________________________________________________
88
Tolerance to cobalt after immunotherapy for cobalt hypersensitivity.
Ann Allergy Asthma Immunol 2012 May;108(5):382-383
abstract
_______________________________________________________________
89
Respiratory syncytial virus infection increases regulated on activation normal T cell expressed and secreted and monocyte chemotactic protein 1 levels in serum of patients with asthma and in human monocyte cultures.
Ann Allergy Asthma Immunol 2012 May;108(5):316-320
abstract
_______________________________________________________________
90
Using latent class growth analysis to identify childhood wheeze phenotypes in an urban birth cohort.
Ann Allergy Asthma Immunol 2012 May;108(5):311-315
abstract
_______________________________________________________________
91
Asthma in the elderly: risk factors and impact on physical function.
Ann Allergy Asthma Immunol 2012 May;108(5):305-310
abstract
_______________________________________________________________
92
Exhaled breath condensate MMP-9 level and its relationship with asthma severity and interleukin-4/10 levels in children.
Ann Allergy Asthma Immunol 2012 May;108(5):300-304
abstract
_______________________________________________________________
93
Impact of climate change on aeroallergens.
Ann Allergy Asthma Immunol 2012 May;108(5):294-299
abstract
_______________________________________________________________
94
Vascular ring presenting as asthma in an 8-year-old.
Ann Allergy Asthma Immunol 2012 May;108(5):291-293
abstract
_______________________________________________________________
95
Food allergy: diagnosis and beyond.
Ann Allergy Asthma Immunol 2012 May;108(5):289-290
abstract
_______________________________________________________________
96
Re: The average Adjusted Symptom Score, a new primary efficacy end-point for specific allergen immunotherapy trials.
Clin Exp Allergy 2012 May;42(5):806
abstract
_______________________________________________________________
97
The role of seasonal grass pollen on childhood asthma emergency department presentations.
Clin Exp Allergy 2012 May;42(5):799-805
abstract
_______________________________________________________________
98
Prediction of asthma exacerbations in children: results of a one-year prospective study.
Clin Exp Allergy 2012 May;42(5):792-798
abstract
_______________________________________________________________
99
Isolation of filamentous fungi from sputum in asthma is associated with reduced post-bronchodilator FEV1.
Clin Exp Allergy 2012 May;42(5):782-791
abstract
_______________________________________________________________
100
Associated demographics of persistent exhaled nitric oxide elevation in treated asthmatics.
Clin Exp Allergy 2012 May;42(5):775-781
abstract
_______________________________________________________________
101
Non-atopic males with adult onset asthma are at risk of persistent airflow limitation.
Clin Exp Allergy 2012 May;42(5):769-774
abstract
_______________________________________________________________
102
Severe asthma: future treatments.
Clin Exp Allergy 2012 May;42(5):706-711
abstract
_______________________________________________________________
103
The investigation of severe asthma to define phenotypes.
Clin Exp Allergy 2012 May;42(5):678-692
abstract
_______________________________________________________________
104
Exacerbations of severe asthma.
Clin Exp Allergy 2012 May;42(5):670-677
abstract
_______________________________________________________________
105
The role of allergy in severe asthma.
Clin Exp Allergy 2012 May;42(5):659-669
abstract
_______________________________________________________________
106
Pathogenesis of severe asthma.
Clin Exp Allergy 2012 May;42(5):625-637
abstract
_______________________________________________________________
107
What is severe asthma?
Clin Exp Allergy 2012 May;42(5):617-624
abstract
_______________________________________________________________
108
Nitric oxide and asthma severity: towards a better understanding of asthma phenotypes.
Clin Exp Allergy 2012 May;42(5):614-616
abstract
_______________________________________________________________
109
Obesity as a risk factor for increased asthma severity and allergic inflammation; cause or effect?
Clin Exp Allergy 2012 May;42(5):612-613
abstract
_______________________________________________________________
110
Special issue on severe asthma.
Clin Exp Allergy 2012 May;42(5):611
abstract
_______________________________________________________________
111
Current treatment of severe asthma.
Clin Exp Allergy 2012 May;42(5):693-705
abstract
_______________________________________________________________
112
Obesity is associated with increased asthma severity and exacerbations, and increased serum immunoglobulin E in inner-city adults.
Clin Exp Allergy 2012 May;42(5):747-759
abstract
_______________________________________________________________
113
Nitric oxide and related enzymes in asthma: relation to severity, enzyme function and inflammation.
Clin Exp Allergy 2012 May;42(5):760-768
abstract
_______________________________________________________________
114
Molecular and clinical rationale for therapeutic targeting of interleukin-5 and its receptor.
Clin Exp Allergy 2012 May;42(5):712-737
abstract
_______________________________________________________________
115
Desensitization for hypersensitivity reactions to medications.
Chem Immunol Allergy 2012;97217-233
abstract
_______________________________________________________________
116
Cutaneous drug eruptions associated with the use of biologies and cutaneous drug eruptions mimicking specific skin diseases.
Chem Immunol Allergy 2012;97203-216
abstract
_______________________________________________________________
117
Cutaneous drug eruptions associated with the use of new oncological drugs.
Chem Immunol Allergy 2012;97191-202
abstract
_______________________________________________________________
118
Immediate and delayed cutaneous reactions to radiocontrast media.
Chem Immunol Allergy 2012;97180-190
abstract
_______________________________________________________________
119
Phototoxic and photoallergic cutaneous drug reactions.
Chem Immunol Allergy 2012;97167-179
abstract
_______________________________________________________________
120
Stevens-Johnson syndrome and toxic epidermal necrolysis.
Chem Immunol Allergy 2012;97149-166
abstract
_______________________________________________________________
121
Drug-induced hypersensitivity syndrome: recent advances in the diagnosis, pathogenesis and management.
Chem Immunol Allergy 2012;97122-138
abstract
_______________________________________________________________
122
Fixed Drug Eruption: The Dark Side of Activation of Intraepidermal CD8+ T Cells Uniquely Specialized to Mediate Protective Immunity.
Chem Immunol Allergy 2012;97106-121
abstract
_______________________________________________________________
123
Drug-induced angioedema.
Chem Immunol Allergy 2012;9798-105
abstract
_______________________________________________________________
124
Uncomplicated drug-induced disseminated exanthemas.
Chem Immunol Allergy 2012;9779-97
abstract
_______________________________________________________________
125
Histopathological patterns indicative of distinct adverse drug reactions.